Vaccines
RNA Therapeutics 2024: From Pandemic Pivots to Precision Powerhouses
2024 marked a transformative year for RNA therapeutics. What began as a pandemic-driven innovation sprint has evolved into a diversified, multi-platform fr...
April 03, 2025 | Analysis
Vaximm Reports Promising Final Data from Phase 2a Trial of Oral Vaccine VXM01 with Avelumab in Recurrent Glioblastoma
Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneering biotechnology company focused on developing innovative immunotherapies, announced fina...
March 27, 2025 | News
China’s Everest Gets FDA Clearance for First mRNA Cancer Vaccine EVM14
EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer ...
March 25, 2025 | News
China’s AIM Vaccine Gets FDA Nod for mRNA Shingles Vaccine Trial
AIM Vaccine Co., developed mRNA shingles vaccine has recently received clinical trial approval from the U.S. Food and Drug Administration (FDA). As o...
March 25, 2025 | News
SK bioscience Ships 750,000 Influenza Vaccine Doses to Southeast Asia and Latin America
750,000 doses of influenza vaccine to be supplied to Southeast Asia and Latin America in the first half of the year. Expanded exports markets ensure yea...
March 12, 2025 | News
AIM Vaccine Secures Production License for World’s First Serum-Free Rabies Vaccine
AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 12, 2025, the company's serum-free iterative rabie...
March 12, 2025 | News
NEC Partners with Nagasaki University and CEPI to Advance AI-Driven mRNA Vaccine for SFTS and Future Epidemic Threats
NEC Partners with Nagasaki University and CEPI to Develop AI-Driven mRNA Vaccine for SFTS and Future Epidemic Threats NEC Corporation (NEC; TSE: 6701) has...
March 10, 2025 | News
AIM Vaccine Secures Clinical Approval for Next-Gen Diploid Rabies Vaccine, Marking a Major Technological Leap
AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 9, 2025, the company's research and development of...
March 10, 2025 | News
Everest Medicines Doses First Patient with AI-Driven Personalized mRNA Cancer Vaccine EVM16 in Landmark Clinical Trial
The first patient has been dosed with EVM16 at Peking University Cancer Hospital, marking a major milestone as Everest's proprietary AI-based tumor neoan...
March 07, 2025 | News
Hong Kong Pharma Stocks Surge as AIM Vaccine Secures U.S. Clinical Approval for mRNA RSV Vaccine
The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively into the pharmaceutical...
February 27, 2025 | News
Biological E. Partners with Bavarian Nordic to Manufacture Chikungunya Vaccine for LMICs in Asia, Africa, and Latin America
The manufacturing agreement is the first step in working together to provide Chikungunya Vaccine to low-and middle-income countries The initial t...
February 25, 2025 | News
SK Bioscience Advances mRNA Vaccine for Japanese Encephalitis with Phase 1/2 Trials in Australia and New Zealand
SK bioscience’s first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026. ...
February 25, 2025 | News
AIM Vaccine Accelerates Global Expansion with FDA Submissions for mRNA Shingles and RSV Vaccines
As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in China is in full swi...
February 25, 2025 | News
CanSinoBIO Showcases Vaccine Innovation and Global Health Commitment at 2025 World Government Summit
CanSino Biologics Inc. (CanSinoBIO or the Company), a leading Chinese vaccine innovator, has been invited to the 2025 World Government Summit in Dubai...
February 18, 2025 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
